Open access
Jul 2026
PEG-GE11-modified nanoplatform for co-delivery of cisplatin and plumbagin in targeted therapy of oral squamous cell carcinoma
This innovative nanoplatform combines active targeting, stimuli-responsive drug release, and chemo-chemodynamic therapy (CCDT), presenting a promising approach to overcome drug resistance and improve the treatment of OSCC.
Zhiliang Nie, Q. Jiang, Xiwen Wan et al.
· RSC Advances · 0 citations